Injected CBD Changed Slow-Wave Sleep but Not REM Sleep in a Historical Rat Experiment

A 1977 rat study found changes in slow-wave sleep after injected CBD without a significant REM-sleep change. Repeated administration produced tolerance to the reported sleep and wakefulness effects.

Dose affected which sleep measure changed

In male Wistar rats, one acute dose reduced latency to slow-wave sleep. A higher tested dose increased slow-wave sleep time and decreased wakefulness. These are different dimensions of sleep: falling into a stage earlier does not necessarily mean spending more total time in it.

The REM comparison was negative

REM sleep was not significantly modified. The result should not be expanded into an improvement in every sleep stage or proof of restorative sleep. It also does not establish subjective sleep quality, daytime functioning or treatment of a diagnosed human sleep disorder.

The repeated-dose response weakened

After daily injections for fifteen days, tolerance developed to the reported effects. This observation belongs to the animal regimen and route. It does not establish that all CBD products lose effects after the same interval or predict oral absorption and dosing in people.

The study supplies a historical sleep-stage and adaptation comparison. It does not establish CBD as a hypnotic treatment or provide a consumer dose recommendation. Species, injection route, sleep-stage endpoints and duration of exposure are essential limits on translation.

Related: interpreting cannabis tolerance claims.

Research cited

Monti JM. Hypnoticlike effects of cannabidiol in the rat. Psychopharmacology (1977). doi:10.1007/BF00497858. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

A review published in 2020 graded psychiatric evidence from studies of CBD and CBD-containing nabiximols. Its recommendation labels should not be quoted as though every underlying intervention was purified CBD or every study was randomized. The included designs ranged widely The review identified 23 relevant studies spanning case reports, case…

Spread the love

Read Article: A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

A 2021 ocular CBD review brought together in-vitro and in-vivo research, proposed molecular targets and possible therapeutic applications. This evidence maps a development pathway; it does not establish that CBD products are effective eye treatments. The experimental system belongs in the conclusion A cellular result can identify a target or…

Spread the love

Read Article: CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

A 2021 review evaluated CBD research on reinforcing, motivational and withdrawal-related drug effects. These outcomes can inform substance-use-disorder research, but an improvement in one cannot establish successful treatment across all of them. The source combined preclinical and clinical reports The review covered alcohol, opioids, cannabinoids, nicotine and psychostimulants. An animal…

Spread the love

Read Article: CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us